FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Diabetes patients Dr. Kamal Kant Kohli24 Dec 2024 8:15 PM ISTThe U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a...
Hitesh Kumar Maheshwari joins Ipca Labs as President - RnD (Formulations) Ruchika Sharma17 Oct 2023 1:30 PM ISTMumbai: Ipca Labs has appointed Hitesh Kumar Maheshwari as President – R&D (Formulations) with effect from 16th October, 2023. "He will be...
Riad Mishlawi to become CEO of Hikma Pharma Ruchika Sharma13 April 2023 12:15 PM ISTNew Delhi: Generic drugmaker Hikma Pharmaceuticals Plc said on Wednesday that Riad Mishlawi, president of the group's injectables business, will...
USFDA nod to Lupin Glycopyrrolate Injection Ruchika Sharma9 Feb 2023 12:05 PM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received approval from the United States Food and Drug Administration...
Hikma Pharma unveils authorized generic of Xyrem in US Ruchika Sharma3 Jan 2023 11:00 AM ISTLondon: Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has announced it has launched an authorized generic version of Jazz...
Hikma Pharma, Junshi Biosciences ink pact for Cancer drug Toripalimab commercialisation in Middle East, North Africa Ruchika Sharma27 Dec 2022 12:20 PM ISTAs part of this collaboration, Hikma has acquired rights to commercialize any combination product that comprises any therapeutically active...
Alembic Pharma bags USFDA nod for alkylating drug Cyclophosphamide Ruchika Sharma14 Nov 2022 11:33 AM ISTVadodara: Drugmaker Alembic Pharmaceuticals Limited today announced that the company has received final approval from the US Food & Drug...
Dr Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer Ruchika Sharma7 Oct 2022 11:15 AM ISTDr Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Glenmark Specialty, Hikma Pharma launch seasonal allergic rhinitis nasal spray in US Roshni Dhar31 Aug 2022 5:39 PM ISTHikma Pharmaceuticals PLC, the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. have...
Glenmark Specialty, Hikma Pharma launch seasonal allergic rhinitis nasal spray RYALTRIS in US Ruchika Sharma31 Aug 2022 1:30 PM ISTThe onset of action for nasal symptom relief occurs within 15 minutes of a patient taking the first dose.
Hikma Pharma, Bio-Thera ink pact to commercialize Ustekinumab biosimilar Ruchika Sharma31 Aug 2021 12:48 PM ISTLondon: Bio-Thera Solutions, Ltd. and Hikma Pharmaceuticals PLC have recently announced that they have entered into a commercialization and license...
Hikma Pharma gets USFDA nod for Kloxxado nasal spray Ruchika Sharma2 May 2021 9:45 AM ISTLondon: Hikma Pharmaceuticals PLC has recently announced the approval of KLOXXADO (naloxone hydrochloride) nasal spray 8mg, by the US Food and Drug...
